Stock Analysts

Lilly’s (LLY) Taltz Gets Approval for Label Expansion in US

Eli Lilly and Company LLY announced that the FDA has approved the label expansion of its psoriasis drug, Taltz, to include the treatment of active psoriatic arthritis (PsA) in adults. We note that Taltz is presently approved for treating moderate-to-severe plaque psoriasis in adults who can have systemic therapy or phototherapy. The drug has grown more than 50% in the first nine months of 2017 and contributed significantly to revenues and volumes. […]

Stock Analysts

Denbury Signs Outstanding Senior Note Exchange Contract

Denbury Resources Inc. DNR enters a privately negotiated agreement with holders of about $610 million of outstanding senior subordinated notes due 2022 and 2023 in exchange for about $466 million in aggregate principal amount of New Notes. The New Notes comprise about $382 million in aggregate principal amount of new 9.25% Senior Secured Second Lien Notes due 2022 (the “New Second Lien Notes”) and about $85 million in aggregate principal amount of new 3.5% Convertible Senior Notes due 2024 (the “New Convertible Notes”). […]

Stock Analysts

Mylan Up on FDA Approval & Amazon’s Rumored Pharmacy Interest

Mylan N.V. MYL and its India-based partner Biocon announced that the FDA has approved their biosimilar version of Roche’s RHHBY Herceptin (trastuzumab). The biosimilar will be available under the tradename of Ogivri and will include all indications of Herceptin in its label including HER-2 positive breast cancer and metastatic stomach cancer […]

Stock Analysts

Is China Petroleum (SNP) a Great Stock for Value Investors?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. […]

Economic Data

Will Tax Cut Passage Be Easy?

Monday, December 4, 2017 Dow futures have rocketed up more than 200 points in this morning’s pre-market on news that the Senate has passed its version of a tax reform bill in the wee hours of Saturday morning. The corporate tax rate shedding 15 percentage points — 35% to 20% — is one of the main items the Senate version shares with the House bill, which now faces reconciliation to make its way to President Trump’s desk, which he would surely sign. Same with the pass-through rate and the elimination of the estate tax. […]

Stock Analysts

Is Murphy USA (MUSA) a Great Stock for Value Investors?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process […]

Stock Analysts

Is Sunoco (SUN) a Great Stock for Value Investors?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process […]